ZHOU Li-man, HAO Yi, MENG Ju-xiang, QIN Fang-fang, QIN Qing-hua, WANG Cong, KONG Fan-dong. One new glycoside naphthopyranone from the Yiling cave-derived Metarhizium anisopliae NHC-M3-2J. Acta Pharmaceutica Sinica, 2023, 58(10): 3076-3081. DOI: 10.16438/j.0513-4870.2023-0346
Citation: ZHOU Li-man, HAO Yi, MENG Ju-xiang, QIN Fang-fang, QIN Qing-hua, WANG Cong, KONG Fan-dong. One new glycoside naphthopyranone from the Yiling cave-derived Metarhizium anisopliae NHC-M3-2J. Acta Pharmaceutica Sinica, 2023, 58(10): 3076-3081. DOI: 10.16438/j.0513-4870.2023-0346

One new glycoside naphthopyranone from the Yiling cave-derived Metarhizium anisopliae NHC-M3-2

  • Seven compounds were isolated from fermentation extract of cave-derived Metarhizium anisopliae NHC-M3-2 by silica gel, semi-preparative HPLC and other chromatographic methods. Their structures were elucidated by UV, IR, MS and NMR methods as 2,3-dehydroindigotide G (1), (-)-regiolone (2), naphtho-γ-pyrone (3), indigotide G (4), indigotide B (5) destruxin A (6) and destruxin B (7). Compound 1 is a new glycoside naphthopyranone compound. The anti-hepatitis B virus (HBV) activity of these compounds was evaluated. The EC50 and CC50 of compound 3 against HBV were 4.5 μmol·L-1 and 92.3 μmol·L-1, respectively. This is the first report of the antiviral activity of compound 3.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return